Halozyme Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 156.94M 58.98M 2024-09
Amgen USD 8.81B 3.16B 2025-03
Baxter International USD 1.76B 344M 2024-12
Cytokinetics USD 938.22M 843.36M 2025-03
DBV Technologies USD 32.5M 4.51M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Indivior 372M 53M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
MannKind USD 47.31M 973K 2025-03
Pfizer USD 1.43B 387M 2025-03
United Therapeutics USD 1.9B 202.7M 2025-03



Halozyme Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.